Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jasmin Ezić"'
Autor:
Lisa T. Huber, Johann M. Kraus, Jasmin Ezić, Amin Wanli, Marco Groth, Simon Laban, Thomas K. Hoffmann, Barbara Wollenberg, Hans A. Kestler, Cornelia Brunner
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 3, Pp 422-446 (2023)
Aim: Recently, a tumor cell-platelet interaction was identified in different tumor entities, resulting in a transfer of tumor-derived RNA into platelets, named further “tumor-educated platelets (TEP)”. The present pilot study aims to investigate
Externí odkaz:
https://doaj.org/article/7f08bddc60874ffa92d65bc1ddf7441a
Autor:
Linda Hofmann, Tsima Abou Kors, Jasmin Ezić, Beate Niesler, Ralph Röth, Sonja Ludwig, Simon Laban, Patrick J. Schuler, Thomas K. Hoffmann, Cornelia Brunner, Valentin Medyany, Marie-Nicole Theodoraki
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Background: Head and neck squamous cell carcinomas (HNSCC) lack tumor-specific biomarkers. Exosomes from HNSCC patients carry immunomodulatory molecules, and correlate with clinical parameters. We compared miRNA profiles of plasma- and saliva-derived
Externí odkaz:
https://doaj.org/article/f4b07b257ef04856b71e8b242130684a
Autor:
Linda Hofmann, Valentin Medyany, Jasmin Ezić, Ramin Lotfi, Beate Niesler, Ralph Röth, Daphne Engelhardt, Simon Laban, Patrick J. Schuler, Thomas K. Hoffmann, Cornelia Brunner, Edwin K. Jackson, Marie-Nicole Theodoraki
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundExosomes contribute to immunosuppression in head and neck squamous cell carcinoma (HNSCC), a tumor entity which lacks specific tumor biomarkers. Plasma-derived exosomes from HNSCC patients correlate with clinical parameters and have potenti
Externí odkaz:
https://doaj.org/article/b081436aafca40e187dd665805d0efb6
Autor:
Annika C. Betzler, Jasmin Ezić, Tsima Abou Kors, Thomas K. Hoffmann, Thomas Wirth, Cornelia Brunner
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The transcriptional co-activator BOB.1/OBF.1 is expressed in both B and T cells. The main characteristic of conventional BOB.1/OBF.1 deficient mice is the complete absence of germinal centers (GCs). This defect was mainly attributed to the defective
Externí odkaz:
https://doaj.org/article/cd50db055ba54440964af69597aaba3b
Publikováno v:
Journal of Health Sciences, Vol 5, Iss 2 (2015)
Introduction: Bioflavonoids delphinidin (2-(3,4,5-Trihydroxyphenyl)chromenylium-3,5,7-triol) and luteolin (2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-chromenone) have been recognized as promising antioxidants and anticancer substances. Due to their exte
Externí odkaz:
https://doaj.org/article/17cf26f3b346456193d7cabf30681f98
Autor:
Lena Mühlenbruch, Tsima Abou-Kors, Marissa L. Dubbelaar, Leon Bichmann, Oliver Kohlbacher, Martin Bens, Jaya Thomas, Jasmin Ezić, Johann M. Kraus, Hans A. Kestler, Adrian von Witzleben, Joannis Mytilineos, Daniel Fürst, Daphne Engelhardt, Johannes Doescher, Jens Greve, Patrick J. Schuler, Marie-Nicole Theodoraki, Cornelia Brunner, Thomas K. Hoffmann, Hans-Georg Rammensee, Juliane S. Walz, Simon Laban
Publikováno v:
British Journal of Cancer. 128:1777-1787
Background The immune peptidome of OPSCC has not previously been studied. Cancer-antigen specific vaccination may improve clinical outcome and efficacy of immune checkpoint inhibitors such as PD1/PD-L1 antibodies. Methods Mapping of the OPSCC HLA lig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dced82b3d981ef6845aecbb8f9e667e6
https://doi.org/10.1038/s41416-023-02197-y
https://doi.org/10.1038/s41416-023-02197-y
Autor:
Julia Butt, Tim Waterboer, Michael Pawlita, Thomas K. Hoffmann, Johannes Doescher, Marie-Nicole Theodoraki, Marlene C. Wigand, Patrick J. Schuler, Cornelia Brunner, Hans A. Kestler, Gunnar Völkel, Johann M. Kraus, Peter Möller, Ralf Marienfeld, Jasmin Ezić, Paolo Boscolo-Rizzo, Gerhard Dyckhoff, Christel C. Herold-Mende, Martina A. Broglie, Andreas Dietz, Gunnar Wichmann, Dirk Jäger, Inka Zörnig, Stefan B. Eichmüller, Lea Schroeder, Dana Holzinger, Dominik S. Gangkofner, Simon Laban
Overall survival by HPV-status. Overall survival stratified by HPV-status based on A) molecular HPV-status, B) seropositivity to HPV-16 E6, C) seropositivity to any high-risk HPV-types and D) by molecular HPV-status if available and seropositivity to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f4bf30bee3bb4df8662e93d73396bf
https://doi.org/10.1158/1078-0432.22470929.v1
https://doi.org/10.1158/1078-0432.22470929.v1
Autor:
Julia Butt, Tim Waterboer, Michael Pawlita, Thomas K. Hoffmann, Johannes Doescher, Marie-Nicole Theodoraki, Marlene C. Wigand, Patrick J. Schuler, Cornelia Brunner, Hans A. Kestler, Gunnar Völkel, Johann M. Kraus, Peter Möller, Ralf Marienfeld, Jasmin Ezić, Paolo Boscolo-Rizzo, Gerhard Dyckhoff, Christel C. Herold-Mende, Martina A. Broglie, Andreas Dietz, Gunnar Wichmann, Dirk Jäger, Inka Zörnig, Stefan B. Eichmüller, Lea Schroeder, Dana Holzinger, Dominik S. Gangkofner, Simon Laban
Patient characteristics (non-oropharyngeal patients)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8196839c19b9f3f07c4969e583cd964d
https://doi.org/10.1158/1078-0432.22470923.v1
https://doi.org/10.1158/1078-0432.22470923.v1
Autor:
Julia Butt, Tim Waterboer, Michael Pawlita, Thomas K. Hoffmann, Johannes Doescher, Marie-Nicole Theodoraki, Marlene C. Wigand, Patrick J. Schuler, Cornelia Brunner, Hans A. Kestler, Gunnar Völkel, Johann M. Kraus, Peter Möller, Ralf Marienfeld, Jasmin Ezić, Paolo Boscolo-Rizzo, Gerhard Dyckhoff, Christel C. Herold-Mende, Martina A. Broglie, Andreas Dietz, Gunnar Wichmann, Dirk Jäger, Inka Zörnig, Stefan B. Eichmüller, Lea Schroeder, Dana Holzinger, Dominik S. Gangkofner, Simon Laban
Purpose:The identification of high-risk patients within human papillomavirus (HPV)-positive and -negative head and neck squamous cell carcinoma (HNSCC) is needed for improved treatment and surveillance strategies. In this study, we set out to discove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::146121ebca10785ff09a0867fe6663f7
https://doi.org/10.1158/1078-0432.c.6527735.v1
https://doi.org/10.1158/1078-0432.c.6527735.v1
Autor:
Annika C. Betzler, Hannah Strobel, Tsima Abou Kors, Jasmin Ezić, Kristina Lesakova, Ronja Pscheid, Ninel Azoitei, Johanna Sporleder, Anna-Rebekka Staufenberg, Robert Drees, Stephanie E. Weissinger, Jens Greve, Johannes Doescher, Marie-Nicole Theodoraki, Patrick J. Schuler, Simon Laban, Toshiro Kibe, Michiko Kishida, Shosei Kishida, Christian Idel, Thomas K. Hoffmann, Marialuisa Lavitrano, Emanuela Grassilli, Cornelia Brunner
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 310
Here, we describe the expression of Bruton’s Tyrosine Kinase (BTK) in head and neck squamous cell carcinoma (HNSCC) cell lines as well as in primary HNSCC samples. BTK is a kinase initially thought to be expressed exclusively in cells of hematopoie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::067b47e8094518dc123c0fafb62814d2
https://hdl.handle.net/10281/402357
https://hdl.handle.net/10281/402357